Clinical trials are divided into phases
Each phase serves a unique purpose:
Phase 1: Focuses on safety and dosage, typically involving a small number of healthy volunteers or patients.
Phase 2: Assesses efficacy (i.e., how well what’s being tested actually works) and side effects in a larger group of patients.
Phase 3: Confirms efficacy, monitors side effects, and compares the new treatment to existing treatments in a larger patient population.
Phase 4: Monitors the long-term safety and effectiveness of treatment after it’s been approved and is on the market.
Clinical trial phases for drugs
Focus on assessing the safety and efficacy of pharmaceutical compounds or biologics for therapeutic purposes. The goal of research is to determine whether the drug can treat, cure, or prevent a medical condition.
Read More
Clinical trials phases for diagnostics
Assess the accuracy, safety, and clinical utility of tests or imaging techniques used to diagnose or monitor medical conditions. The trial goal is to determine a diagnostic’s ability to provide accurate and reliable results.
Read More
Clinical trials for medical devices
Evaluate the safety, performance, and effectiveness of medical equipment or instruments. The research objective is to assess whether the device can be used for diagnosis, treatment, or monitoring of medical conditions.
Read More
Key differences between trials
The differences ensure effective and safe development of new medical treatments and technologies.
Standardization: Drug trials are more standardized in phase structure than device and diagnostic trials.
Focus: Drug trials focus on safety and efficacy, device trials on safety and performance, and diagnostics on accuracy and reliability.
Regulatory pathways: Each category follows different regulatory guidelines, reflecting unique risks and benefits.
Endpoints: Drug trials focus on clinical outcomes, devices on technical performance, and diagnostics on accuracy metrics like sensitivity and specificity.